Loading clinical trials...
Loading clinical trials...
CLOCC Trial (Chemotherapy + Local Ablation Versus Chemotherapy) Randomized Phase II Study Of Local Treatment Of Liver Metastases By Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone In Patients With Unresectable Colorectal Liver Metastases
Conditions
Interventions
bevacizumab
FOLFOX regimen
+5 more
Locations
43
Austria
Allgemeines Krankenhaus - Universitatskliniken
Vienna, Austria
Ziekenhuis Netwerk Antwerpen Middelheim
Antwerp, Belgium
Institut Jules Bordet
Brussels, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Clinique Universitaire De Mont-Godinne
Mont-Godinne Yvoir, Belgium
Start Date
May 1, 2002
Primary Completion Date
June 1, 2007
Last Updated
September 24, 2012
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions